PRINCIPEN
What it isAminopenicillin; Listeria, enterococcal and susceptible Gram-negative infection.
Why this oneIt is the drug for Listeria meningitis, which cephalosporins do not cover.
What limits itBeta-lactamase producers escape it. Rash with concurrent EBV; frequent dosing.
Read the full label on DailyMed ↗
| FDA dosing | Population | Start | Target | Max |
|---|---|---|---|---|
| Genitourinary/GI tract infections | Adults & children >20 kg | 500 mg QID | ||
| Respiratory tract infections | Adults & children >20 kg | 250 mg QID | ||
| Gonorrhea | Adult | Single 3.5 g dose with 1 g probenecid | ||
| Genitourinary/GI tract infections | Children <=20 kg | 100 mg/kg/day divided QID | ||
| Respiratory tract infections | Children <=20 kg | 50 mg/kg/day divided TID-QID |
Renal Undefined
Hepatic Undefined
Pregnancy Animal reproduction studies revealed no evidence of impaired fertility or fetal harm; no adequate and well-controlled studies in pregnant women.
Lactation Undefined
NO BOXED WARNINGS
Principal riskHypersensitivity; beta-lactamase producers escape it
Cost, est. cash$10–$300/month
Generic entry1985
Legacy pregnancy categoryB
Defining liabilityAllergy, gastrointestinal effects and agent-specific renal, hepatic, hematologic or interaction risks.

Open Ampicillin in the interactive console ↗
